Welltower Inc.’s WELL first-quarter 2025 normalized funds from operations (FFO) per share of $1.20 surpassed the Zacks Consensus Estimate of $1.15. The reported figure improved 18.8% year over year. Results reflect a rise in revenues on a year-over-year basis. The total portfolio same-store net operating income (SSNOI) increased year over year, driven by SSNOI growth in the seniors housing operating (SHO) portfolio. The company increased its guidance for 2025 normalized FFO per share. WELL recorded revenues of $2.42 billion in the quarter, beating the Zacks Consensus Estimate of $2.37 billion. The top line increased 30.3% year over year. Quarter in Detail for WELL The SHO portfolio’s same-store revenues increased 9.6% year over year, backed by 400 basis points year-over-year growth in average occupancy and Revenue per Occupied Room (’RevPOR’) growth of 5.9%. The company’s total portfolio SSNOI grew 12.9% year over year, supported by SSNOI growth in its SHO portfolio of 21.7%. WELL’s pro-rata gross investments in the first quarter totaled $2.8 billion. This included $2.7 billion in acquisitions and loan funding and $142 million in development funding. It completed and placed into service nine development projects for an aggregate pro rata investment amount of $475 million. Welltower also completed pro-rata property dispositions of $381 million and loan repayments of $123 million in the quarter. In the first quarter, property operating expenses increased 33.3% to $1.46 billion year over year. In March 2025, Welltower entered into a definitive agreement to acquire a portfolio of 38 ultra-luxury senior housing communities and nine development parcels for C$4.6 billion, which will be operated by a preeminent seniors housing owner, Amica Senior Lifestyles. WELL’s Balance Sheet Position As of March 31, 2025, WELL had $8.6 billion of available liquidity, comprising $3.6 billion of available cash and restricted cash, and full capacity under its $5 billion line of credit. Credit Rating Upgrade for WELL On March 31, 2025, S&P increased the company’s credit rating to "A-" with a stable outlook and Moody's increased its credit rating to "A3" with a stable outlook. WELL’s Dividend Update On April 28, Welltower announced a cash dividend for the first of quarter 2025 of 67 cents per share. The dividend will be paid out on May 22 to stockholders of record as of May 14, 2025. This will mark the company’s 216th consecutive quarterly cash dividend payout. WELL’s 2025 Guidance Welltower increased 2025 normalized FFO per share guidance range to $4.90-$5.04, up from the previous range of $4.79-$4.95. The Zacks Consensus Estimate for the same is pegged at $4.95, which lies within the company's guided range. Story Continues WELL’s guidance assumes the average blended SSNOI growth of 10.00-13.25%, comprising 16.5-21.5% growth in Seniors Housing Operating, 3.0-4.0% in Seniors Housing Triple-net, 2.0-3.0% in Outpatient Medical and 2.0-3.0% in Long-Term/Post-Acute Care. Welltower expects to fund an additional $340 million of development in 2025 relating to projects underway as of March 31, 2025. Currently, the company carries a Zacks Rank #2 (Buy). Welltower Inc. Price, Consensus and EPS Surprise Welltower Inc. price-consensus-eps-surprise-chart | Welltower Inc. Quote Performance of Other REITs SL Green Realty Corp. SLG reported first-quarter 2025 FFO per share of $1.40, which surpassed the Zacks Consensus Estimate of $1.27. The company had reported an FFO of $3.07 per share in the year-ago period. Results reflected improved average rental rates on the Manhattan office leases signed in the period and higher same-store cash net operating income (NOI). However, elevated interest expenses undermined the results to some extent. Presently, SLG carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. Healthpeak Properties, Inc. DOC reported first-quarter 2025 FFO as adjusted per share of 46 cents, meeting the Zacks Consensus Estimate. This compares to the FFO of 45 cents reported in the prior year. (See the Zacks Earnings Calendar to stay ahead of market-making news.) Results reflect better-than-anticipated revenues. Growth in total merger-combined same-store cash (adjusted) NOI was witnessed across the portfolio. However, higher interest expenses affected the results to some extent. Currently, DOC carries a Zacks Rank #3. Note: Anything related to earnings presented in this write-up represents FFO, a widely used metric to gauge the performance of REITs. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report SL Green Realty Corporation (SLG):Free Stock Analysis Report Healthpeak Properties, Inc. (DOC):Free Stock Analysis Report Welltower Inc. (WELL):Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research
Welltower's Q1 FFO & Revenues Beat Estimates, Same Store NOI Rises
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...